A new guideline on complicated urinary tract infections (UTIs) could redefine treatment in Australia and globally.

US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...

For children with febrile urinary tract infection (UTI), stopping antibiotic treatment 3 days after clinical improvement increased the risk of recurrence but reduced antibiotic use and related side ...

Urine dipstick demonstrates higher sensitivity and specificity than laboratory urinalysis for diagnosing urinary tract ...

The FDA approved a new antibiotic for UTIs from drugmaker GSK. The drug, Blujepa, is for women and girls ages 12 and up.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

The UTI Children's Hybrid Fund- Direct has an AUM of 4316.01 crores & has delivered CAGR of 13.82% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 1.54%.

GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...

The UTI Children's Hybrid Fund - Scholarship Plan has an AUM of 4316.01 crores & has delivered CAGR of 13.53% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 1.74%.

GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...